ArticleTherapeutic advances in medical oncology2025

Trastuzumab and pertuzumab plus carboplatin-based neoadjuvant therapy for HER2-positive breast cancer: a prospective cohort study with integrated genomic and transcriptomic biomarker analysis.

Xiaoyan Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.